Bacteriophage-receptor binding proteins for multiplex detection of Staphylococcus and Enterococcus in blood.
Silvio B SantosAlexandra P CunhaMariana MacedoCatarina L NogueiraAna BrandãoSusana P CostaLuís D R MeloJoana AzeredoCarla M CarvalhoPublished in: Biotechnology and bioengineering (2020)
Healthcare-associated infections (HCAIs) affect hundreds of millions of patients, representing a significant burden for public health. They are usually associated to multidrug resistant bacteria, which increases their incidence and severity. Bloodstream infections are among the most frequent and life-threatening HCAIs, with Enterococcus and Staphylococcus among the most common isolated pathogens. The correct and fast identification of the etiological agents is crucial for clinical decision-making, allowing to rapidly select the appropriate antimicrobial and to prevent from overuse and misuse of antibiotics and the consequent increase in antimicrobial resistance. Conventional culture methods are still the gold standard to identify these pathogens, however, are time-consuming and may lead to erroneous diagnosis, which compromises an efficient treatment. (Bacterio)phage receptor binding proteins (RBPs) are the structures responsible for the high specificity conferred to phages against bacteria and thus are very attractive biorecognition elements with high potential for specific detection and identification of pathogens. Taking into account all these facts, we have designed and developed a new, fast, accurate, reliable and unskilled diagnostic method based on newly identified phage RBPs and spectrofluorometric techniques that allows the multiplex detection of Enterococcus and Staphylococcus in blood samples in less than 1.5 hr after an enrichment step.
Keyphrases
- antimicrobial resistance
- biofilm formation
- real time pcr
- pseudomonas aeruginosa
- staphylococcus aureus
- gram negative
- multidrug resistant
- public health
- healthcare
- loop mediated isothermal amplification
- end stage renal disease
- decision making
- label free
- ejection fraction
- risk factors
- high throughput
- candida albicans
- newly diagnosed
- cystic fibrosis
- chronic kidney disease
- acinetobacter baumannii
- high resolution
- chronic pain
- peritoneal dialysis
- prognostic factors
- smoking cessation
- combination therapy
- quantum dots
- binding protein
- bioinformatics analysis
- replacement therapy